| Dr Alan Steven Quint, MD | |
|
17 2nd St E, Suite 206, Kalispell, MT 59901-6107 | |
| (406) 755-3148 | |
| (406) 755-3499 |
| Full Name | Dr Alan Steven Quint |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 17 2nd St E, Kalispell, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891776787 | NPI | - | NPPES |
| 0000056069 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 3771 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan Steven Quint, MD 17 2nd St E, Suite 206, Kalispell, MT 59901-6107 Ph: (406) 755-3148 | Dr Alan Steven Quint, MD 17 2nd St E, Suite 206, Kalispell, MT 59901-6107 Ph: (406) 755-3148 |
News Archive
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Approximately 12,000 women are diagnosed with cervical cancer each year in the United States and another 4,000 die annually from the disease. However, most cervical cancers are preventable through immunization against the human papillomavirus (HPV). A pivotal international phase 2/3 clinical trial involving Moffitt Cancer Center faculty demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease.
Following the release of his proposed Fiscal Year 2012 budget, AIDS Healthcare Foundation, the largest global AIDS organization, today criticized President Barack Obama and his administration for requests for budget funding levels for HIV/AIDS programs that are grossly inadequate to the need.
EpiCept Corporation today announced that at a meeting earlier this week with the U.S. Food and Drug Administration (FDA), the Company was granted permission to initiate immediately the Phase III clinical development of AmiKet.
Researchers from the Uniformed Services University of the Health Sciences (USU) are pursuing efforts to find new ways to prevent and to treat the increasing numbers of combat troops who are suffering from injuries due to traumatic brain injury (TBI).
› Verified 2 days ago
Joseph Hugh Boyle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Claremont St, Suite C, Kalispell, MT 59901 Phone: 406-758-5155 | |
Robert D Schimpff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 202 Conway Dr, Suite 100, Kalispell, MT 59901 Phone: 406-751-5666 Fax: 406-755-0971 | |
Kurt D Lindsay, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Commons Way Ste C, Kalispell, MT 59901 Phone: 406-752-5095 Fax: 406-752-5058 | |
Constance Mash, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Heritage Way, Kalispell, MT 59901 Phone: 406-756-3950 Fax: 406-756-3957 | |
Tanner Ferderer, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Commons Way Ste C, Kalispell, MT 59901 Phone: 406-752-5095 Fax: 406-751-3079 | |
Victor C. Houser Iii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 355 1st Avenue West N, Kalispell, MT 59901 Phone: 406-755-6200 Fax: 406-755-6208 | |
Melanie A. Klawiter, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Commons Way Ste C, Kalispell, MT 59901 Phone: 406-752-5095 |